Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 2:2
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 3
1 (33.3%)Apnex Clinical Study of the Hypoglossal Nerve Stimulation (HGNS®) System to Treat Obstructive Sleep Apnea
Phase 3
Terminated
- Conditions
- Obstructive Sleep Apnea
- First Posted Date
- 2011-10-05
- Last Posted Date
- 2015-04-15
- Lead Sponsor
- Apnex Medical, Inc.
- Target Recruit Count
- 132
- Registration Number
- NCT01446601
- Locations
- 🇺🇸
MidAmerica Neuroscience Research Institute, Lenexa, Kansas, United States
🇺🇸Veritas Clinical Specialties, Topeka, Kansas, United States
🇺🇸Kentucky Research Group, Louisville, Kentucky, United States
US Clinical Study of the Apnex Medical Hypoglossal Nerve Stimulation (HGNS) System to Treat Obstructive Sleep Apnea
Phase 2
Completed
- Conditions
- Obstructive Sleep Apnea
- First Posted Date
- 2010-09-29
- Last Posted Date
- 2015-04-15
- Lead Sponsor
- Apnex Medical, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT01211444
- Locations
- 🇺🇸
University of California San Francisco, San Francisco, California, United States
🇺🇸Saint Vincent Hospital, Indianapolis, Indiana, United States
🇺🇸University of Minnesota, Minneapolis, Minnesota, United States
Australian Clinical Study of the Apnex Medical HGNS System to Treat Obstructive Sleep Apnea
Phase 2
Completed
- Conditions
- Obstructive Sleep Apnea
- First Posted Date
- 2010-08-23
- Last Posted Date
- 2015-04-15
- Lead Sponsor
- Apnex Medical, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT01186926
News
No news found